Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
4
×
biotech
boston blog main
boston top stories
cancer
san francisco blog main
san francisco top stories
amgen
boehringer ingelheim
cancer drugs
clinical trials
deals
eli lilly
ipo
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
sanofi
adaptive biotechnologies
alector
allergan
american cancer society
apollomics
avelumab
bernie sanders
beta bionics
big pharma
bill & melinda gates foundation trust
biontech
biovex
black diamond therapeutics
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
bristol-myers squibb
checkpoint inhibitor
What
cancer
4
×
pharmaceutical
4
×
bio
companies
hasn’t
medicines
appetite
approved
bets
black
bread
butter
buyout
cancer’s
cash
combo
comes
cut
date
dating
deal
diabetes
diamond’s
disease
drugs
effective
eli
enticed
evidence
frontiers
game
giant
grabbed
happening
hold
immunotherapies
ipo
kgaa
known
latest
Language
unset
Current search:
" national blog main "
×
cancer
×
pharmaceutical
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines